clinical trial · NCT00200902
Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression
University of California, Los Angeles·phase4·completed·n = 88
DepressionVenlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro)PlaceboInterpersonal Clinical Interaction (ICI)
brief summary
This study will use measurements of depression symptoms and brain activity to determine what factors may influence an individual's response to treatment for depression.
started
Aug 1, 2005
primary completion
Jun 1, 2009
completion
Jun 1, 2009
last updated
Aug 13, 2024
detailed description
We are using depression symptom measurements and measurements of brain electrical activity (EEG) to determine what factors may influence whether a patient is likely to show a response to antidepressant medication, placebo, or only clinical visits (without the use of pills) during a treatment trial for depression.
official title
Factors of Treatment Response in Major Depressive Disorder
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol